Re:Non-Indians have benefited most from patent regime in India
by belorn on Wednesday August 28, 2013 @04:37PM
(#6292473)
While someone might die tomorrow for lack of medicine not invented yet, someone will die today for not being able to buy the patent licensed medicine. While it might be deadly not to provide that incentive for invention, question does lay if its moral to let people die today, just so some other people might not die tomorrow.
Of course, evergreening is an extra evil in itself, and lets not forget that pharma also get a extra special monopoly after the patent has expired just for doing drug trials.
http://thelastpsychiatrist.com/2005/10/if_france_gets_its_wa...
And getting mad at Novartis in this case for "evergreening" also isn't entirely fair, because up until 2003/5 India was the wild west when it came to drugs, and thus Novartis couldn't really sell it there anyway. If India had product patents when Gleevec was invented in 1995, maybe they would be on course to have the generic soon. Instead, the rest of the world is subsidizing cheap drugs for India. We invent, we pay, they benefit.